{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:46:32Z","timestamp":1791294392074,"version":"4.1.0"},"reference-count":51,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2015,5,30]]},"DOI":"10.3233\/jad-150072","type":"journal-article","created":{"date-parts":[[2015,5,31]],"date-time":"2015-05-31T08:53:20Z","timestamp":1433062400000},"page":"525-533","source":"Crossref","is-referenced-by-count":78,"title":["Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOE \u025b4 Carriers"],"prefix":"10.1177","volume":"46","author":[{"given":"Erika J.","family":"Starks","sequence":"first","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Patrick O\u2019Grady","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan M.","family":"Hoscheidt","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie M.","family":"Racine","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Carlsson","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Geriatric Research Education and Clinical Center, Wm. S. Middleton Memorial Veterans Hospital, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"UCL Institute of Neurology, Queen Square, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"The Torsten S\u00f6derberg Professorship at the Royal Swedish Academy of Sciences, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozioma C.","family":"Okonkwo","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Wisconsin Alzheimer\u2019s Institute, Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Puglielli","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Geriatric Research Education and Clinical Center, Wm. S. Middleton Memorial Veterans Hospital, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Asthana","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Geriatric Research Education and Clinical Center, Wm. S. Middleton Memorial Veterans Hospital, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.\u00a0Maritza","family":"Dowling","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey E.","family":"Gleason","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Geriatric Research Education and Clinical Center, Wm. S. Middleton Memorial Veterans Hospital, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozalyn M.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Geriatric Research Education and Clinical Center, Wm. S. Middleton Memorial Veterans Hospital, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Davenport-Sis","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeAnn\u00a0M.","family":"DeRungs","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Sager","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Wisconsin Alzheimer\u2019s Institute, Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Geriatric Research Education and Clinical Center, Wm. S. Middleton Memorial Veterans Hospital, Madison, WI, USA"},{"name":"Wisconsin Alzheimer\u2019s Institute, Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara B.","family":"Bendlin","sequence":"additional","affiliation":[{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA"},{"name":"Wisconsin Alzheimer\u2019s Institute, Wisconsin School of Medicine and Public Health, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150072_ref1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/M14-0737","article-title":"Diabetes in midlife and cognitive change over 20 years: A cohort study","volume":"161","author":"Rawlings","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.3233\/JAD-150072_ref2","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: The Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-150072_ref3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J"},{"key":"10.3233\/JAD-150072_ref4","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150072_ref5","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1210\/en.2009-0695","article-title":"Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes","volume":"150","author":"Kim","year":"2009","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-150072_ref6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-150072_ref7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1749-6632.1999.tb07839.x","article-title":"A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer\u2019s disease","volume":"893","author":"Frolich","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-150072_ref8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150072_ref9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.3233\/JAD-150072_ref10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1471-4159.2009.06320.x","article-title":"Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer\u2019s disease","volume":"111","author":"Liu","year":"2009","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-150072_ref12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamaneurol.2013.284","article-title":"Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging","volume":"70","author":"Thambisetty","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-150072_ref13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2990.2008.00948.x","article-title":"Beta-amyloid deposition in brains of subjects with diabetes","volume":"35","author":"Alafuzoff","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-150072_ref14","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.49.5.1306","article-title":"Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study","volume":"49","author":"Heitner","year":"1997","journal-title":"Neurology"},{"key":"10.3233\/JAD-150072_ref15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.3233\/JAD-150072_ref16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders","volume":"67","author":"Profenno","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-150072_ref17","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.neurobiolaging.2011.12.017","article-title":"Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI","volume":"33","author":"Vos","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150072_ref18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150072_ref19","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.3233\/JAD-150072_ref20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00702-012-0801-3","article-title":"Cerebrospinal fluid amyloid-beta 2-42 is decreased in Alzheimer\u2019s, but not in frontotemporal dementia","volume":"119","author":"Bibl","year":"2012","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-150072_ref21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: A follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150072_ref22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0891988705281882","article-title":"Middle-aged children of persons with Alzheimer\u2019s disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer\u2019s Prevention","volume":"18","author":"Sager","year":"2005","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-150072_ref23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150072_ref24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-150072_ref25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-11-0844","article-title":"Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents","volume":"166","author":"Aradillas-Garcia","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.3233\/JAD-150072_ref26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4274\/Jcrpe.1127","article-title":"A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents","volume":"5","author":"Singh","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.3233\/JAD-150072_ref27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.2040-1124.2011.00113.x","article-title":"Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population","volume":"2","author":"Yamada","year":"2011","journal-title":"J Diabetes Investig"},{"key":"10.3233\/JAD-150072_ref28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1472-6823-13-47","article-title":"Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: Effect of gender and age: EPIRCE cross-sectional study","volume":"13","author":"Gayoso-Diz","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"10.3233\/JAD-150072_ref29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.11.012","article-title":"The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE epsilon3\/epsilon3 genotype","volume":"7","author":"Johnson","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150072_ref30","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: A cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-150072_ref31","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/srep01339","article-title":"Ratio of Abeta42\/P-Tau181p in CSF is associated with aberrant default mode network in AD","volume":"3","author":"Li","year":"2013","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-150072_ref32","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150072_ref33","doi-asserted-by":"crossref","first-page":"13635","DOI":"10.1523\/JNEUROSCI.3949-07.2007","article-title":"Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms","volume":"27","author":"Planel","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150072_ref34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","article-title":"Brain metabolic dysfunction at the core of Alzheimer\u2019s disease","volume":"88","author":"de la Monte","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-150072_ref35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbadis.2004.06.017","article-title":"Tau phosphorylation: Physiological and pathological consequences","volume":"1739","author":"Stoothoff","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-150072_ref36","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2174\/15672050113109990006","article-title":"Increased Alzheimer\u2019s disease neuropathology is associated with type 2 diabetes and ApoE epsilon.4 carrier status","volume":"10","author":"Malek-Ahmadi","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-150072_ref37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/ajmg.b.30694","article-title":"Diabetes and overweight associate with non-APOE4 genotype in an Alzheimer\u2019s disease population","volume":"147B","author":"Profenno","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.3233\/JAD-150072_ref38","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150072_ref39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.3233\/JAD-150072_ref40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.2000.tb06371.x","article-title":"Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer\u2019s disease differ according to apolipoprotein-E genotype","volume":"903","author":"Craft","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-150072_ref41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease: Relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-150072_ref42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.fob.2014.02.011","article-title":"Expression of human apolipoprotein E4 reduces insulin-receptor substrate 1 expression and Akt phosphorylation in the ageing liver","volume":"4","author":"Ong","year":"2014","journal-title":"FEBS Open Bio"},{"key":"10.3233\/JAD-150072_ref43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbadis.2011.06.011","article-title":"Insulin is differentially related to cognitive decline and atrophy in Alzheimer\u2019s disease and aging","volume":"1822","author":"Burns","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-150072_ref44","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/01.wnl.0000276952.91704.af","article-title":"Peripheral insulin and brain structure in early Alzheimer disease","volume":"69","author":"Burns","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-150072_ref45","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2337\/diacare.25.8.1371","article-title":"Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers","volume":"25","author":"Marques-Vidal","year":"2002","journal-title":"Diabetes Care"},{"key":"10.3233\/JAD-150072_ref46","doi-asserted-by":"crossref","first-page":"e21041","DOI":"10.1371\/journal.pone.0021041","article-title":"The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning","volume":"6","author":"Qu","year":"2011","journal-title":"PloS One"},{"key":"10.3233\/JAD-150072_ref47","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso","year":"2003","journal-title":"Diabetes Care"},{"key":"10.3233\/JAD-150072_ref48","first-page":"681","article-title":"Molecular features of hypothalamic plaques in Alzheimer\u2019s disease","volume":"139","author":"Standaert","year":"1991","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-150072_ref49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-150072_ref50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.3233\/JAD-150072_ref51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","article-title":"Role of mitochondrial dysfunction in insulin resistance","volume":"102","author":"Kim","year":"2008","journal-title":"Circ Res"},{"key":"10.3233\/JAD-150072_ref52","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1242\/bio.20135447","article-title":"CSF p-Tau levels in the prediction of Alzheimer\u2019s disease","volume":"2","author":"Kandimalla","year":"2013","journal-title":"Biology Open"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:14Z","timestamp":1777370534000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,30]]},"references-count":51,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-150072","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,30]]}}}